Cytek reaffirms $205M-$212M 2026 revenue outlook as U.S. growth rebounds
Cytek Biosciences, Inc. Common Stock · LABORATORY ANALYTICAL INSTRUMENTS · Now $4.24
-23% in 7d after detection
Post-detection moves
1h
—
1d
-11%
3d
-20%
7d
-23%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS